about
Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine.Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.Triptans and CGRP blockade - impact on the cranial vasculature.Migraine and cluster headache - the common linkPACAP38 dose-response pilot study in migraine patientsEffect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical TrialOnset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical StudiesDual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?The Stereotypical Image of a Person With Migraine According to Mass Media
P50
Q40844180-B177354A-3F8F-4FF9-9452-5AE4C66791AAQ40844188-9FDC4465-A6E6-417C-BC11-B5FDBBB48180Q42706186-13D9FAD7-835C-4F6C-B47F-A49EF9A0E461Q57153177-8D0EC9D1-2DC2-4164-9AD9-17BA9B9F1215Q89207148-AFB90A59-C30A-420E-B824-24386DE52C19Q89482170-E2D08977-0672-49D8-9FFD-714A49585F24Q90142357-D74717AB-459B-4675-B51B-479B7BA15E56Q95288367-06ADC97B-622F-4908-B337-042F40F7B3DBQ95849859-56FA3A38-721B-4F44-ACBD-E30B36FCE1C5
P50
description
researcher ORCID ID = 0000-0002-6218-4744
@en
wetenschapper
@nl
name
Anne Luise Haulund Vollesen
@ast
Anne Luise Haulund Vollesen
@en
Anne Luise Haulund Vollesen
@es
Anne Luise Haulund Vollesen
@nl
type
label
Anne Luise Haulund Vollesen
@ast
Anne Luise Haulund Vollesen
@en
Anne Luise Haulund Vollesen
@es
Anne Luise Haulund Vollesen
@nl
prefLabel
Anne Luise Haulund Vollesen
@ast
Anne Luise Haulund Vollesen
@en
Anne Luise Haulund Vollesen
@es
Anne Luise Haulund Vollesen
@nl
P106
P21
P31
P496
0000-0002-6218-4744